37149211000001103: Erythromycin ethyl succinate 500mg tablets (P.I.E. Pharma Ltd) (product)

SNOMED CT Concept\Pharmaceutical / biologic product\...

\UK product\Actual medicinal product\Erythromycin ethyl succinate 500mg tablets (P.I.E. Pharma Ltd)
\UK product\Virtual medicinal product\Product containing precisely erythromycin 500 milligram/1 each conventional release oral tablet\Erythromycin ethyl succinate 500mg tablets (P.I.E. Pharma Ltd)
\UK product\Virtual therapeutic moiety\Erythromycin\Product containing only erythromycin in oral dose form (medicinal product form)\Product containing precisely erythromycin 500 milligram/1 each conventional release oral tablet\Erythromycin ethyl succinate 500mg tablets (P.I.E. Pharma Ltd)

\Medicinal product\Medicinal product categorized by disposition\Product containing erythromycin\Erythromycin\Product containing only erythromycin in oral dose form (medicinal product form)\Product containing precisely erythromycin 500 milligram/1 each conventional release oral tablet\Erythromycin ethyl succinate 500mg tablets (P.I.E. Pharma Ltd)
\Medicinal product\Medicinal product categorized by disposition\Product containing erythromycin\Product containing erythromycin in oral dose form (medicinal product form)\Product containing only erythromycin in oral dose form (medicinal product form)\Product containing precisely erythromycin 500 milligram/1 each conventional release oral tablet\Erythromycin ethyl succinate 500mg tablets (P.I.E. Pharma Ltd)
\Medicinal product\Medicinal product categorized by structure\Product containing macrolide\Medicinal product containing macrolide and acting as antibacterial agent (product)\Product containing erythromycin\Erythromycin\Product containing only erythromycin in oral dose form (medicinal product form)\Product containing precisely erythromycin 500 milligram/1 each conventional release oral tablet\Erythromycin ethyl succinate 500mg tablets (P.I.E. Pharma Ltd)
\Medicinal product\Medicinal product categorized by structure\Product containing macrolide\Medicinal product containing macrolide and acting as antibacterial agent (product)\Product containing erythromycin\Product containing erythromycin in oral dose form (medicinal product form)\Product containing only erythromycin in oral dose form (medicinal product form)\Product containing precisely erythromycin 500 milligram/1 each conventional release oral tablet\Erythromycin ethyl succinate 500mg tablets (P.I.E. Pharma Ltd)
\Medicinal product\Medicinal product categorized by therapeutic role\Medicinal product acting as antiinfective agent (product)\Medicinal product acting as antibacterial agent (product)\Medicinal product containing macrolide and acting as antibacterial agent (product)\Product containing erythromycin\Erythromycin\Product containing only erythromycin in oral dose form (medicinal product form)\Product containing precisely erythromycin 500 milligram/1 each conventional release oral tablet\Erythromycin ethyl succinate 500mg tablets (P.I.E. Pharma Ltd)
\Medicinal product\Medicinal product categorized by therapeutic role\Medicinal product acting as antiinfective agent (product)\Medicinal product acting as antibacterial agent (product)\Medicinal product containing macrolide and acting as antibacterial agent (product)\Product containing erythromycin\Product containing erythromycin in oral dose form (medicinal product form)\Product containing only erythromycin in oral dose form (medicinal product form)\Product containing precisely erythromycin 500 milligram/1 each conventional release oral tablet\Erythromycin ethyl succinate 500mg tablets (P.I.E. Pharma Ltd)
\Medicinal product\Product manufactured as oral dose form\Product containing erythromycin in oral dose form (medicinal product form)\Product containing only erythromycin in oral dose form (medicinal product form)\Product containing precisely erythromycin 500 milligram/1 each conventional release oral tablet\Erythromycin ethyl succinate 500mg tablets (P.I.E. Pharma Ltd)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 12-Jun 2019. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module

220671000001119 Erythromycin ethyl succinate 500mg tablets (P.I.E. Pharma Ltd) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

220681000001117 Erythromycin ethyl succinate 500mg tablets (P.I.E. Pharma Ltd) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
Erythromycin ethyl succinate 500mg tablets (P.I.E. Pharma Ltd)	Is a	Actual medicinal product	true	Inferred relationship	Existential restriction modifier
Erythromycin ethyl succinate 500mg tablets (P.I.E. Pharma Ltd)	Has excipient	Excipient not declared	true	Inferred relationship	Existential restriction modifier
Erythromycin ethyl succinate 500mg tablets (P.I.E. Pharma Ltd)	Is a	Product containing precisely erythromycin 500 milligram/1 each conventional release oral tablet	true	Inferred relationship	Existential restriction modifier
Erythromycin ethyl succinate 500mg tablets (P.I.E. Pharma Ltd)	Has NHS dm+d (dictionary of medicines and devices) basis of strength substance	Erythromycin	true	Inferred relationship	Existential restriction modifier
Erythromycin ethyl succinate 500mg tablets (P.I.E. Pharma Ltd)	Has NHS dm+d (dictionary of medicines and devices) controlled drug category	Controlled drug category No Controlled Drug Status	true	Inferred relationship	Existential restriction modifier
Erythromycin ethyl succinate 500mg tablets (P.I.E. Pharma Ltd)	Has dispensed dose form	Tablet	true	Inferred relationship	Existential restriction modifier
Erythromycin ethyl succinate 500mg tablets (P.I.E. Pharma Ltd)	VMP prescribing status (attribute)	VMP valid as a prescribable product	true	Inferred relationship	Existential restriction modifier
Erythromycin ethyl succinate 500mg tablets (P.I.E. Pharma Ltd)	Has specific active ingredient	Erythromycin ethylsuccinate	true	Inferred relationship	Existential restriction modifier
Erythromycin ethyl succinate 500mg tablets (P.I.E. Pharma Ltd)	VMP non-availability indicator	Available	true	Inferred relationship	Existential restriction modifier
Erythromycin ethyl succinate 500mg tablets (P.I.E. Pharma Ltd)	Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator	NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction not available	true	Inferred relationship	Existential restriction modifier

Inbound Relationships	Type	Active	Source	Characteristic	Refinability	Group
Erythromycin ethyl succinate 500mg tablets (P.I.E. Pharma Ltd) 28 tablet	Has AMP	True	Erythromycin ethyl succinate 500mg tablets (P.I.E. Pharma Ltd)	Inferred relationship	Existential restriction modifier

This concept is not in any reference sets

Back to Start

Id	Description	Lang	Type	Status	Case?	Module
220671000001119	Erythromycin ethyl succinate 500mg tablets (P.I.E. Pharma Ltd)	en	Synonym	Active	Entire term case sensitive	SNOMED CT United Kingdom drug extension module
220681000001117	Erythromycin ethyl succinate 500mg tablets (P.I.E. Pharma Ltd) (product)	en	Fully specified name	Active	Entire term case sensitive	SNOMED CT United Kingdom drug extension module